Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-10 · accession 0001209191-21-055866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-14 | 2021-09-10+ | ORIC | Chacko Jacob | Pres, CEO, Dir | S - Sale | $25.05 | -5,743 | 10.8K | -35% | -$143.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-10 | S | D | 2,942 | $25.08 | 13,609 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 2,942 shares sold in the price range of $25.00 to $25.28 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2021-09-13 | S | D | 2,801 | $25.02 | 10,808 | D | — | — | (F3) Represents the weighted average share price of an aggregate total of 2,801 shares sold in the price range of $25.00 to $25.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |